Biolex and Medarex Sign Research Collaboration Agreement

Biolex, a privately held protein therapeutics company, has announced the signing of a new agreement with Medarex, an antibody therapeutics company, to create a commercial line for an undisclosed Medarex monoclonal antibody using the Biolex LEX System. Including this project, Biolex has a total of 11 partner proteins with five different top-tier partners to date, two of which have already advanced to GLP scale-up production.

Yahoo News (http://biz.yahoo.com/prnews/050204/nyf036x_1.html)